+ Follow CURRENT MEDICAL RESEARCH AND OPINION Tag
Array
(
[results] => Array
(
[0] => Array
(
[ArticleID] => 719781
[Title] => Drug significantly cuts hypoglycemic events
[Summary] => A newly published study showed that the Novartis oral diabetes medication vildagliptin, when taken with metformin, caused no hypoglycemia, was well adhered to and improved blood sugar levels in South Asian patients with type 2 diabetes mellitus (T2DM) fasting during daylight hours for Ramadan.
[DatePublished] => 2011-08-25 00:00:00
[ColumnID] => 133272
[Focus] => 0
[AuthorID] =>
[AuthorName] =>
[SectionName] => Science and Environment
[SectionUrl] => science-and-environment
[URL] =>
)
)
)
CURRENT MEDICAL RESEARCH AND OPINION
Array
(
[results] => Array
(
[0] => Array
(
[ArticleID] => 719781
[Title] => Drug significantly cuts hypoglycemic events
[Summary] => A newly published study showed that the Novartis oral diabetes medication vildagliptin, when taken with metformin, caused no hypoglycemia, was well adhered to and improved blood sugar levels in South Asian patients with type 2 diabetes mellitus (T2DM) fasting during daylight hours for Ramadan.
[DatePublished] => 2011-08-25 00:00:00
[ColumnID] => 133272
[Focus] => 0
[AuthorID] =>
[AuthorName] =>
[SectionName] => Science and Environment
[SectionUrl] => science-and-environment
[URL] =>
)
)
)
abtest
August 25, 2011 - 12:00am